Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - February 19, 2026 13 Q1 2026 BULLSEYE CHARTS This resource is supported by Learn More UBC partners with biopharma to modernize evidence… Source RELATED ARTICLESMORE FROM AUTHOR Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers Introducing The Psychedelic News Feed Podcast Field Notes #5: ‘Psychedelics Week’ in Washington D.C.
